Â¥
3.24
Nov 13
New Key Statistics Module, Z-Score and F-Score
SZSE:300267 Key Ratios
Market Cap ¥ M | 6,682.84 |
Enterprise Value ¥ M | 6,527.01 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.41 |
Price/Sales | 5.60 |
Price/Free Cash Flow | 216.00 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 1,192.00 |
EPS (TTM) ¥ | -0.13 |
Beneish M-Score | -2.79 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -1,330.00 |
EV-to-EBIT | -25.64 |
EV-to-EBITDA | -25.64 |
PEG | -- |
Shares Outstanding M | 2,062.60 |
Net Margin (%) | -21.88 |
Operating Margin % | -10.06 |
Pre-tax Margin (%) | -22.14 |
Quick Ratio | 1.64 |
Current Ratio | 2.68 |
ROA % (ttm) | -4.78 |
ROE % (ttm) | -5.38 |
ROIC % (ttm) | -2.69 |
Dividend Yield % | -- |
Altman Z-Score | 6.65 |
SZSE:300267 Number of Guru Trades
SZSE:300267 Volume of Guru Trades
Gurus Latest Trades with SZSE:300267
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300267 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hunan Er-Kang Pharmaceutical Co Ltd Insider Transactions
No Available Data